Skip to main content

Market Overview

Spark Therapeutics (NASDAQ: )

0.00 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2019
Pre-Market
EPS:
REV:
-1.26
10.707M

-1.72
22.447M

Q2 2019
Pre-Market
EPS:
REV:
-0.77
25.185M
-1.21
28.43M
-1.66
13.503M
-37.19%
-52.5%
Q1 2019
Pre-Market
EPS:
REV:
-1.25
15.676M
-1.23
27.85M
-1.43
20.771M
-16.26%
-25.42%
Q4 2018
Pre-Market
EPS:
REV:
-1.74
7.408M
-1.07
28.64M
-1.75
13.157M
63.55%
-54.06%
Q3 2018
Pre-Market
EPS:
REV:
-1.90
1.9M
-0.98
26.18M
-1.26
10.707M
28.57%
-59.1%
Q2 2018
Pre-Market
EPS:
REV:
-1.86
1.483M
-0.10
29M
-0.77
25.185M
670%
-13.16%
Q1 2018
Pre-Market
EPS:
REV:
-1.70
1.274M
-0.34
53.93M
-1.25
15.676M
267.65%
-70.93%
Q4 2017
Pre-Market
EPS:
REV:
-1.21
1.303M
-1.68
7.78M
-1.74
7.408M
3.57%
-4.78%
Q3 2017
Pre-Market
EPS:
REV:
-1.07
1.303M
-1.81
1.46M
-1.90
1.9M
4.97%
30.14%
Q2 2017
Pre-Market
EPS:
REV:
-1.04
1.289M

-1.86
1.483M

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!